MedTrace Logo

Topical Voltaren in Otitis Externa

NCT00523120 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2016-04-20

No results posted yet for this study

Summary

Voltaren being a Non-steroidal anti-inflammatory drug (NSAID) drug may be used as a single drug therapy in otitis externa being both therapeutic and analgesic thus reducing consumption of oral analgesia.

Conditions

  • Otitis Externa

Interventions

DRUG

diclofenac sodium

topical solution used in ear 5 drops 8 3/day

DRUG

dexotc

aural drops

Sponsors & Collaborators

  • Sieff Medical Center

    lead OTHER

Principal Investigators

  • victor kizhner, m.d. · Sieff Medical Center, Safed, ISRAEL

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-09-30
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00523120 on ClinicalTrials.gov